Econ Financial Services Corp Abb Vie Inc. Transaction History

Econ Financial Services Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 26, 2022	SELL	$107.43 - $135.93 $756,092 - $956,675	-7,038 Closed	0 $0
Q2 2019 Aug 08, 2019	BUY	$65.7 - $83.98 $174,564 - $223,134	2,657 Added 60.65%	7,038 $512,000
Q1 2019 May 08, 2019	BUY	$77.14 - $90.79 $74,594 - $87,793	967 Added 28.32%	4,381 $353,000
Q4 2018 Feb 07, 2019	BUY	$77.85 - $96.01 $265,779 - $327,778	3,414 New	3,414 $315,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Econ Financial Services Corp, based on Form 13F filings with the SEC.

Stay updated on Econ Financial Services Corp with notifications on news.